All articles tagged: Adverse effect of unspecified agents primarily affecting the cardiovascular system (T46.905)


HealthDay 09 July at 03.42 PM Semaglutide Cuts MACE in People With Overweight, Obesity, Regardless of HbA1c Semaglutide reduces cardiovascular events, regardless of baseline glycated hemoglobin (HbA1c), among people with overweight or obesity and established atherosclerotic cardiovascular disease, according to a study published online June 22 in Diabetes Care.Ildiko Lingvay, M.D., from the University of Texas Southwestern Medical Center in Da # Cardiology # Diabetes & Endocrinology # Internal Medicine # Family Practice 0 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
HealthDay 28 June at 03.03 PM Bariatric Surgery Tied to Lower Risk of MACE, Death in Obesity, Sleep Apnea Metabolic surgery is associated with significantly lower risk of major adverse cardiovascular events (MACE) compared with nonsurgical management among patients with moderate-to-severe obstructive sleep apnea (OSA) and obesity, according to a study published online June 21 in the Journal of the American College of Cardiology.Ali Aminian, # Cardiology # Surgery # Gastroenterology # Pulmonology 0 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
HealthDay 27 June at 03.03 PM hs-cTnT Linked to MACE, Mortality in Rheumatoid Arthritis For patients with rheumatoid arthritis (RA), a detectable level of high-sensitivity cardiac troponin T (hs-cTnT) is associated with increased risk of major adverse cardiovascular events (MACE) and all-cause mortality, according to a research letter published online June 15 in the Journal of Rheumatology.Brittany N. Weber, M.D., Ph.D., # Cardiology # Rheumatology 0 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn


MedScape 28 November at 01.50 AM Sleep-Disordered Breathing Common After Stroke Sleep-disordered breathing remains common after stroke, affecting 60% of patients and showing no decline in prevalence from 2010 to 2023, a new meta-analysis suggested. 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
Medpage Today 24 November at 08.00 PM IDH Inhibitor Activity in Brain Cancer Persists With Longer Follow-Up HOUSTON -- Progression-free survival (PFS) in IDH-mutant low-grade glioma remained twice as high in adults who received vorasidenib (Voranigo) after surgery versus placebo, according to a follow-up analysis of a pivotal clinical... 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
Medical xPress 23 November at 01.50 PM RNA editing is the next frontier in gene therapy—here's what you need to know The United States Food and Drug Administration has just approved the first-ever clinical trial that uses CRISPR-Cas13 RNA editing. Its aim is to treat an eye disease called wet age-related macular degeneration that causes vision loss in millions of older people worldwide. 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
HealthDay 22 November at 04.44 PM Semaglutide, Liraglutide May Reduce Hospitalization Risk for Alcohol Use Disorder Semaglutide and liraglutide are associated with a reduced risk for hospitalization due to alcohol use disorder (AUD), according to a study published online Nov. 13 in JAMA Psychiatry.Markku Lähteenvuo, M.D., Ph.D., from the University of Eastern Finland in Kuopio, and colleagues conducted an observational study in Sweden using data from 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
Medpage Today 17 November at 10.31 PM Two Treatments That Don't Work for Osteoarthritis WASHINGTON -- If you're looking for nonsurgical osteoarthritis (OA) treatments with fewer side effects than ordinary pain relievers, two randomized trials presented here with negative results should at least narrow your search... 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
MedScape 11 November at 07.56 AM Scoring System Could Mean Better Access to Lung Transplant Scoring system could improve access for hard-to-match candidates due to height and blood type. 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn

Medical xPress 07 November at 07.50 AM How key results could influence health policy The results of some congressional races may foreshadow who will have outsize health policy influence in Congress next year. 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
Medpage Today 05 November at 07.00 PM Mpox Cases in Congo May Be Stabilizing GOMA, Congo -- Some health officials say mpox cases in Congo appear to be "stabilizing" -- a possible sign that the main epidemic for which the World Health Organization (WHO) made a global emergency declaration in August... 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
Medical xPress 02 November at 07.40 AM Insulin resistance caused by sympathetic nervous system over-activation, a paradigm-shifting study finds Rutgers Robert Wood Johnson Medical School and collaborating institutions have found that overnutrition leads to insulin resistance and metabolic disorders through increased activity of the sympathetic nervous system (SNS). The study shows that reducing SNS activity can prevent insulin resistance induced by a high-fat diet, suggesting a new understanding of how obesity causes insulin resistance. 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
MedScape 31 October at 06.30 AM Report: Rethink Race-Based Adjustments in Clinical Tools The slow adoption of race-neutral tools may harm patient care outcomes, according to a new report from the National Academies of Sciences, Engineering, and Medicine. 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn